Metallothionein expression in basaloid proliferations overlying dermatofibromas and in basal cell carcinomas

British Journal of Dermatology

Volumn 136, Issue 1, 1997, Pages 30-34

  Rossen, K ^a   Haerslev, T ^b   Hou Jensen, K ^c   Jacobsen, G Krag ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AMAGER HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

METALLOTHIONEIN;

ARTICLE; BASAL CELL CARCINOMA; CELL PROLIFERATION; DERMATOFIBROMA; EPIDERMIS HYPERPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031033203     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb08742.x     Document Type: Article

References (24)

1. Biberstein H. Fibrome mit atypischer epitelwucherung. Arch Dermatol Syphilol 1931; 164: 69-81.
2. Cramer R, Cramer HJ. Über de pseudobasaliomatose Epithelhyperplasie der haut. Arch Klin Exp Derm 1963; 216: 231-45.
3. Rahbari H, Mehregan AH. Adnexal displacement and regression in association with histiocytoma (dermatofibroma). J Cutan Pathol 1985; 12: 94-102.
4. Goette DK, Helwig EB. Basal cell carcinomas and basal cell carcinoma-like changes overlying dermatofibromas. Arch Dermatol 1975; 111: 589-92.
5. Rossen K, Hou-Jensen K, Werdelin O. Altered expression of β-2-microglobulin in basaloid proliferations overlying dermatofibromas. Acta Derm Venereol (Stockh) 1993; 73: 419-21.
6. Fujisava H, Matsushima Y, Hoshino M et al. Differentiation of basal cell epithelioma-like changes overlying dermatofibroma. Acta Derm Venereol (Stockh) 1991; 71: 354-6.
7. Haerslev T, Rossen K, Hou-Jensen K, Krag Jacobsen G. Immunohistochemical detection of p53 in epidermal proliferations overlying dermatofibromas. Acta Derm Venereol (Stockh) 1995; 75: 187-9.
8. Nath R, Kambadur R, Gulati S et al. Molecular aspects, physiological function and clinical significance of metallothioneins. Crit Rev Food Sci Nutr 1988; 27: 41-85.
9. Karin M. Metallothioneins: proteins in search of function. Cell 1985; 41: 9-10.
10. Chubatsu LS, Meneghini R. Metallothionein protects DNA from oxidative damage. Biochem J 1993; 1: 193-8.
11. Loher H, Robson T. Overexpression of metallothionein in CHO cells and its effect on cell killing by ionizing radiation and alkylating agents. Carcinogenesis 1989; 10: 2279-84.
12. Wood D, Klein E, Fair W, Chaganti R. Metallothionein gene expression in bladder cancer exposed to cisplatin. Mod Pathol 1993; 6: 33-5.
13. Hashiba H, Hosoi J, Karasawa M et al. Induction of metallothionein mRNA by tumor promoters in mouse skin and its constitutive expression in papillomas. Mol Carcinog 1989; 2: 95-100.
14. Hamer DH. Metallothionein. Annu Rev Biochem 1986, 55: 913-51.
15. 3 in cultured cells and in mice. Proc Natl Acad Sci USA 1987; 84: 8810-14.
16. Slater EP, Cato ABC, Karin M et al. Progesterone induction of metallothionein-IIA gene expression. Mol Endocrinol 1988; 2: 485-91.
17. Haerslev T, Jacobsen GK, Nedergaard L, Zedeler K. Immunohistochemical detection of metallothionein in primary breast carcinomas and their axillary lymph node metastases. Pathol Res Pract 1994; 190: 675-81.
18. Zelger B, Hittmair A, Schir M et al. Immunohistochemically demonstrated metallothionein expression in malignant melanoma. Histopathology 1993; 23: 257-64.
19. van den Oord JJ, De Ley M. Distribution of metallothionein in normal and pathological human skin. Arch Dermatol Res 1994; 286: 62-8.
20. Zelger B, Sindoroff A, Höpfl R et al. Metallothionein expression in non-melanoma skin cancer. An immunohistochemical study. Appl Immunohistochem 1994; 2: 254-60.
21. Jasani B, Elmers ME. Immunohistochemical detection of metallothionein. Methods Enzymol 1991; 205: 95-107.
22. Jones PH, Harper S, Watt FM. Stem cell patterning and fate in human epidermis. Cell 1995; 80: 83-93.
23. Rochart A, Kobayashi K, Barrandom Y. Location of stem cells of human hair follicles by clonal analysis. Cell 1994; 76: 1063-73.
24. Emmett AJJ. Surgical analysis and biological behaviour of 2277 basal cell carcinomas. Aust NZ J Surg 1990; 60: 855-63.